![Alvaro Plaza Reyes Profile](https://pbs.twimg.com/profile_images/1016987803551444992/khOPvFFP_x96.jpg)
Alvaro Plaza Reyes
@Aplarey
Followers
214
Following
1K
Statuses
369
Postdoctoral Researcher at CABIMER. Passionate about stem cells, cell therapy for retinal diseases, genome editing and research ethics.
Sevilla, Spain
Joined April 2011
RT @isciverse: What is a PhD? Open Access #PhD #PhDlife #academics #AcademicChatter #AcademicTwitter #Postdocs #R…
0
191
0
As always it was a great opportunity to present my work at #ISSCR2024 This is definitely one the best meetings to catch up on the latest advancements on the stem cell field, network and reconnect with esteemed colleagues. @ISSCR @FProgresoysalud @MSCActions
0
1
24
RT @fredrik_lanner: Join my lab @karolinskainst for PhD studies in Early human embryo development, co-supervised by @simonelsasser and Andr…
0
21
0
RT @FProgresoysalud: 👩🏽🔬 Nuestra investigadora en @cabimer, Berta de la Cerda, estudia las enfermedades degenerativas de la #retina 📹 En…
0
5
0
Enhorabuena a los organizadores del II Congreso Europeo de Pacientes Macula - Retina. Ha sido un evento enriquecedor que ha unido a expertos y pacientes en la lucha contra las enfermedades de la retina. #MaculaRetina2023 @macularetina
0
0
3
🔗 Don't forget to join our dedicated Discord server for in-depth discussions, knowledge sharing, and Q&As on gene editing and iPSC-based models! Connect with experts and peers. Join us now: #geneediting #virtualcommunity
0
0
2
Thrilled to present my latest research on human pluripotent stem cell-derived retinal therapies for macular degeneration at #EVER2023 in Valencia! Grateful for the engaging discussions and invaluable feedback. #Ophthalmology #StemCellResearch #VisionScience #TravelGrant
3
1
13
RT @Josolimon: Nuevo episodio de #somosoutliers !! Hablamos con @Aplarey sobre #terapiasavanzadas en #retina, sobre #innovación científica…
0
1
0
RT @FProgresoysalud: Nuestros investigadores en @cabimer están desarrollando una #retina artificial para estudiar en detalle la enfermedad…
0
9
0